round white pills

Worcester Laboratories as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 74 markets providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India,

For over nine decades, making a difference to patients has inspired every aspect of Worcester Laboratories work. A responsible corporate citizen, Worcester Laboratories humanitarian approach to healthcare in pursuit of its purpose of Caring for Life and deep-rooted community links wherever it is present, make it a partner of choice for global health bodies and stakeholders.


people on conference table looking at talking woman
people on conference table looking at talking woman
person in black long sleeve shirt holding persons hand
person in black long sleeve shirt holding persons hand
We value it from the core of our heart Our products are manufactured by experts in their domin, under the most stringent control WHO, GMP certification that conform up to international standard. Worcester Laboratories fundamental elements are based on providing"Quality Products with affordability" so that patients can trust.
Worcester Laboratories' journey began in 2022 with the purpose of making healthcare accessible to all
We have leveraged and invested in our manufacturing capital through facilities that are cGMP compliant and approved globally. This has facilitated the company to attain a global leadership position in the pharmaceutical sector.
The confidence of patients and healthcare professionals in our products has strengthened over the years due to consistent and timely delivery of highly dependable products. We continue to strive to retain this confidence by diligently manufacturing high quality medicines and implementing innovative, path breaking technologies to deliver superior quality products.
Taking the principle of 'Caring for Life' forward, we have worked towards enhancing the affordability of medicines worldwide. We were able do this through cost and complexity rationalisation, product portfolio enhancement, process/yield improvements and alternate vendor development.We have over 1500 products in 65 therapeutic categories available in over 50 dosage forms. These capabilities range from the development of a simple molecule to highly complex multi-chiral centres molecule with a distinction of affordability and highest quality. Our capacities include our own facilities and in licensed facilities which support both generic and the biotech business. Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.
we commenced commercial production at our state-of-the-art manufacturing unit for formulations at Baddi Himachal Pradesh. We also ensured the formulation manufacturing of existing facilities at Baddi to service increasing demand across markets. Besides the new facility, all the existing facilities are upgraded regularly to meet current cGMP, Safety, Health and Environmental Standards. Various initiatives are taken towards energy and water conservation. Our journey towards achieving operational excellence across functions was driven through our efforts to de-bottleneck resources, cycle time reduction, setting internal benchmarks for material and manpower productivity.
We have scaled up several key APIs through yield improvement, cycle time reduction and cost improvement projects. The continued focus on process and operational improvements has resulted in reducing solvent losses to less than 15% thereby reducing environmental impact. Similarly, batch size increase of about 55 products in formulations was carried out during the year resulting in improvement in productivity. We are now on a path to digitise the manufacturing operations by integrating all process-related machines to server to capture real-time process parameters for better operations control, improvement in productivity, and enhanced compliance status.
A group of people walking down a street next to tall buildings

Manufacturing

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.

Quality

Worcester Quality as a centre of excellence assures a culture of compliance and follows systematic interventions to consistently meet or exceed quality standards.

Our Mission

To deliver quality pharma products and reliable third-party manufacturing services with integrity.

Third Party

We provide reliable third party manufacturing services, ensuring your pharma products meet high standards and reach the market efficiently.

PCD Franchise

Our PCD pharma franchise service supports entrepreneurs with quality products and marketing assistance to grow their business

© 2022 worcester. All rights reserved.

COMPANY INFO:

Located in: #453 Behra Banjar ,Amtrar ,Distt Kangra, --176056 Himachal Pradesh

Branch office-Andheri west Mumbai (Maharastra)

Business hours: Mon–Sat, 10.00–17:00

Phone No :-+919317348500 ,+919317448500

Email: info@worcester.in